Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Agnieszka Ida"'
Autor:
Wojciech A. Cieślikowski, Piotr Milecki, Monika Świerczewska, Agnieszka Ida, Michał Kasperczak, Agnieszka Jankowiak, Michał Nowicki, Klaus Pantel, Catherine Alix-Panabières, Maciej Zabel, Andrzej Antczak, Joanna Budna-Tukan
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 4; Pages: 608
The aim of the present study was to verify whether the baseline circulating tumor cell (CTC) count might serve as a predictor of overall survival (OS) and metastasis-free survival (MFS) in patients with high-risk prostate cancer (PCa) during a follow
Autor:
Wojciech A Cieślikowski, Monika Świerczewska, Maciej Zabel, Agnieszka Ida, Agnieszka Jankowiak, Catherine Alix-Panabières, Andrzej Antczak, Klaus Pantel, Michał Nowicki, D. Azria, Martine Mazel, Joanna Budna-Tukan
Publikováno v:
Cancers
Cancers, MDPI, 2019, 11 (6), pp.802. ⟨10.3390/cancers11060802⟩
Cancers, Vol 11, Iss 6, p 802 (2019)
Volume 11
Issue 6
Cancers, MDPI, 2019, 11 (6), pp.802. ⟨10.3390/cancers11060802⟩
Cancers, Vol 11, Iss 6, p 802 (2019)
Volume 11
Issue 6
The characterization of circulating tumor cells (CTCs) can lead to a promising strategy for monitoring residual or relapsing prostate cancer (PCa) after local therapy. The aim of this study was to compare three innovative technologies for CTC enumera
Autor:
Joanna Budna-Tukan, Catherine Alix-Panabières, Michał Nowicki, Wojciech A Cieślikowski, Agnieszka Ida, Andrzej Antczak, Monika Świerczewska, Agnieszka Jankowiak, Maciej Zabel, Michał Hrab, Martine Mazel, Klaus Pantel, Piotr Milecki
Publikováno v:
Cancers
Volume 12
Issue 1
Cancers, Vol 12, Iss 1, p 160 (2020)
Cancers, MDPI, 2020, 12 (1), pp.160. ⟨10.3390/cancers12010160⟩
Volume 12
Issue 1
Cancers, Vol 12, Iss 1, p 160 (2020)
Cancers, MDPI, 2020, 12 (1), pp.160. ⟨10.3390/cancers12010160⟩
The aim of this study was to investigate whether the enumeration of circulating tumor cells (CTCs) in blood can differentiate between true localized and metastatic prostate cancer. A cross-sectional study of 104 prostate cancer patients with newly di
Autor:
Zbigniew Kwias, Berna Beverloo, Weronika Majer, Malgorzata I. Srebniak, Hans A.R. Bluyssen, Agnieszka Ida, Joanna Wesoly, Jacek Wojciechowicz, Katarzyna Kluzek, Adrian Silesian, Kinga Huminska, Robert van der Helm, Tomasz Milecki, Tomasz Wrzesinski
Publikováno v:
Oncotarget, 8(17), 28558-28574. Impact Journals LLC
Oncotarget
Oncotarget
// Katarzyna Kluzek 1, * , Malgorzata I. Srebniak 2, * , Weronika Majer 3 , Agnieszka Ida 4 , Tomasz Milecki 4 , Kinga Huminska 3, 5 , Robert M. van der Helm 2 , Adrian Silesian 1 , Tomasz M. Wrzesinski 3 , Jacek Wojciechowicz 5 , Berna H. Beverloo 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a116648f113296f0ed3fdcea5e62ddb4
https://pure.eur.nl/en/publications/246ab7e5-9b1e-4e86-93c8-6287f618ae60
https://pure.eur.nl/en/publications/246ab7e5-9b1e-4e86-93c8-6287f618ae60
Autor:
Rachel H. Giles, Joanna Poźniak, Joanna Szumska, Hans A.R. Bluyssen, Tomasz Wrzesinski, Elżbieta Zodro, Joanna Wesoly, Zbigniew Kwias, Wojciech A Cieślikowski, Agnieszka Ida, Malgorzata Szelag
Publikováno v:
BMC Cancer, 15, 518. BioMed Central
BMC Cancer
BMC Cancer
Background VHL inactivation is the most established molecular characteristic of clear cell renal cell carcinoma (ccRCC), with only a few additional genes implicated in development of this kidney tumor. In recently published ccRCC gene expression meta
Autor:
Joanna Wesoly, Elżbieta Zodro, Zbigniew Kwias, Agnieszka Ida, Marcin Jaroszewski, Hans A.R. Bluyssen, Tomasz Wrzesinski
Publikováno v:
Tumour Biology
In this paper, we provide a comprehensive summary of available clear cell renal cell carcinoma (ccRCC) microarray data in the form of meta-analysis of genes differentially regulated in tumors as compared to healthy tissue, using effect size to measur